Genome Research scroll

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Published online before print January 13, 2003, 10.1101/gr.214102. Article published online before print in January 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow All Versions of this Article:
GR-2141Rv1
12/2/232    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eaves, I. A.
Right arrow Articles by Glynne, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eaves, I. A.
Right arrow Articles by Glynne, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Vol. 12, Issue 2, 232-243, February 2002

Combining Mouse Congenic Strains and Microarray Gene Expression Analyses to Study a Complex Trait: The NOD Model of Type 1 Diabetes

Iain A. Eaves,1 Linda S. Wicker,2,5 Ghassan Ghandour,3 Paul A. Lyons,1 Laurence B. Peterson,4 John A. Todd,1,6 and Richard J. Glynne3

1 Juvenile Diabetes Research Foundation/ Wellcome Trust (JDRF/WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Wellcome Trust/Medical Research Council (MRC) Building, Addenbrooke's Hospital, Cambridge, CB2 2XY, UK; 2 Department of Immunology and Rheumatology, Merck Research Laboratories, Rahway, New Jersey 07065, USA; 3 Eos Biotechnology, Inc., South San Francisco, California 94080, USA; 4 Department of Pharmacology, Merck Research Laboratories, Rahway, New Jersey 07065, USA

Combining congenic mapping with microarray expression profiling offers an opportunity to establish functional links between genotype and phenotype for complex traits such as type 1 diabetes (T1D). We used high-density oligonucleotide arrays to measure the relative expression levels of >39,000 genes and ESTs in the NOD mouse (a murine model of T1D and other autoimmune conditions), four NOD-derived diabetes-resistant congenic strains, and two nondiabetic control strains. We developed a simple, yet general, method for measuring differential expression that provides an objective assessment of significance and used it to identify >400 gene expression differences and eight new candidates for the Idd9.1 locus. We also discovered a potential early biomarker for autoimmune hemolytic anemia that is based on different levels of erythrocyte-specific transcripts in the spleen. Overall, however, our results suggest that the dramatic disease protection conferred by six Idd loci (Idd3, Idd5.1, Idd5.2, Idd9.1, Idd9.2, and Idd9.3) cannot be rationalized in terms of global effects on the noninduced immune system. They also illustrate the degree to which regulatory systems appear to be robust to genetic variation. These observations have important implications for the design of future microarray-based studies in T1D and, more generally, for studies that aim to combine genome-wide expression profiling and congenic mapping.

[The supplemental research data accompanying this article are available through the authors' web site (http://www-gene.cimr.cam.ac.uk/todd/), and the array data have been submitted to the GEO data repository (http://www.ncbi.nlm.nih.gov/geo/) under accession no. GSE11]


5 Present address: JDRF/WT Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Cambridge, CB2 2XY, UK

6 Corresponding author.


12:232-243 ©2002 by Cold Spring Harbor Laboratory Press  ISSN 1088-9051/02 $5.00

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Irie, B. Reck, Y. Wu, L. S. Wicker, S. Howlett, D. Rainbow, E. Feingold, and W. M. Ridgway
Genome-Wide Microarray Expression Analysis of CD4+ T Cells from Nonobese Diabetic Congenic Mice Identifies Cd55 (Daf1) and Acadl as Candidate Genes for Type 1 Diabetes
J. Immunol., January 15, 2008; 180(2): 1071 - 1079.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. G. Wilming, J. G. R. Gilbert, K. Howe, S. Trevanion, T. Hubbard, and J. L. Harrow
The vertebrate genome annotation (Vega) database
Nucleic Acids Res., January 11, 2008; 36(suppl_1): D753 - D760.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
S. B. English and A. J. Butte
Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes
Bioinformatics, November 1, 2007; 23(21): 2910 - 2917.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Jordan, J. M. Fletcher, D. Pellicci, and A. G. Baxter
Slamf1, the NKT Cell Control Gene Nkt1
J. Immunol., February 1, 2007; 178(3): 1618 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. M. Hines, P. L. Hoffman, S. Bhave, L. Saba, A. Kaiser, L. Snell, I. Goncharov, L. LeGault, M. Dongier, B. Grant, et al.
A Sex-Specific Role of Type VII Adenylyl Cyclase in Depression
J. Neurosci., November 29, 2006; 26(48): 12609 - 12619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Ivakine, O. M. Gulban, S. M. Mortin-Toth, E. Wankiewicz, C. Scott, D. Spurrell, A. Canty, and J. S. Danska
Molecular genetic analysis of the idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice.
J. Immunol., March 1, 2006; 176(5): 2976 - 2990.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Li, L. Lu, K. F. Manly, E. J. Chesler, L. Bao, J. Wang, M. Zhou, R. W. Williams, and Y. Cui
Inferring gene transcriptional modulatory relations: a genetical genomics approach
Hum. Mol. Genet., May 1, 2005; 14(9): 1119 - 1125.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. S. Vukkadapu, J. M. Belli, K. Ishii, A. G. Jegga, J. J. Hutton, B. J. Aronow, and J. D. Katz
Dynamic interaction between T cell-mediated {beta}-cell damage and {beta}-cell repair in the run up to autoimmune diabetes of the NOD mouse
Physiol Genomics, April 14, 2005; 21(2): 201 - 211.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. F. Dominiczak, D. Graham, M. W. McBride, N. J.R. Brain, W. K. Lee, F. J. Charchar, M. Tomaszewski, C. Delles, and C. A. Hamilton
Cardiovascular Genomics and Oxidative Stress
Hypertension, April 1, 2005; 45(4): 636 - 642.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. A. Hinojos, E. Boerwinkle, M. Fornage, and P. A. Doris
Combined Genealogical, Mapping, and Expression Approaches to Identify Spontaneously Hypertensive Rat Hypertension Candidate Genes
Hypertension, April 1, 2005; 45(4): 698 - 704.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Yan, R. M. Rerko, P. Platzer, D. Dawson, J. Willis, M. Tong, E. Lawrence, J. Lutterbaugh, S. Lu, J. K. V. Willson, et al.
From the Cover: 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-{beta}-induced suppressor of human gastrointestinal cancers
PNAS, December 14, 2004; 101(50): 17468 - 17473.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
M. Kirst, A. A. Myburg, J. P.G. De Leon, M. E. Kirst, J. Scott, and R. Sederoff
Coordinated Genetic Regulation of Growth and Lignin Revealed by Quantitative Trait Locus Analysis of cDNA Microarray Data in an Interspecific Backcross of Eucalyptus
Plant Physiology, August 1, 2004; 135(4): 2368 - 2378.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. E. Eckenrode, Q. Ruan, P. Yang, W. Zheng, R. A. McIndoe, and J.-X. She
Gene Expression Profiles Define a Key Checkpoint for Type 1 Diabetes in NOD Mice
Diabetes, February 1, 2004; 53(2): 366 - 375.
[Abstract] [Full Text]


Home page
GeneticsHome page
M. Perez-Enciso, M. A. Toro, M. Tenenhaus, and D. Gianola
Combining Gene Expression and Molecular Marker Information for Mapping Complex Trait Genes: A Simulation Study
Genetics, August 1, 2003; 164(4): 1597 - 1606.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Tabakoff, S. V. Bhave, and P. L. Hoffman
Selective Breeding, Quantitative Trait Locus Analysis, and Gene Arrays Identify Candidate Genes for Complex Drug-Related Behaviors
J. Neurosci., June 1, 2003; 23(11): 4491 - 4498.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. W. McBride, F. J. Carr, D. Graham, N. H. Anderson, J. S. Clark, W. K. Lee, F. J. Charchar, M. J. Brosnan, and A. F. Dominiczak
Microarray Analysis of Rat Chromosome 2 Congenic Strains
Hypertension, March 1, 2003; 41(3): 847 - 853.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Pravenec, C. Wallace, T. J. Aitman, and T. W. Kurtz
Gene Expression Profiling in Hypertension Research: A Critical Perspective
Hypertension, January 1, 2003; 41(1): 3 - 8.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
L. AUJAME, N. BURDIN, and M. VICARI
How Microarrays Can Improve Our Understanding of Immune Responses and Vaccine Development
Ann. N.Y. Acad. Sci., December 1, 2002; 975(1): 1 - 23.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
W J Lemon, H Bernert, H Sun, Y Wang, and M You
Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays
J. Med. Genet., September 1, 2002; 39(9): 644 - 655.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Genes Dev. Learn. Mem.
Protein Science RNA Genome Res.